{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:24:22Z","timestamp":1792808662463,"version":"4.5.0"},"reference-count":71,"publisher":"The Endocrine Society","issue":"1","license":[{"start":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T00:00:00Z","timestamp":1604707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Catherine L. Heron and Albert C. Schneider Vanguard Charitable","id":[{"id":"https:\/\/ror.org\/038kx6d50","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Amiodarone is a class III antiarrhythmic drug containing 37% iodine by weight, with a structure similar to that of thyroid hormones. Deiodination of amiodarone releases large amounts of iodine that can impair thyroid function, causing either hypothyroidism or thyrotoxicosis in susceptible individuals reflecting ~20% of patients administered the drug. Not only the excess iodine, but also the amiodarone (or its metabolite, desethylamiodarone) itself may cause thyroid dysfunction by direct cytotoxicity on thyroid cells. We present an overview of the epidemiology and pathophysiology of amiodarone-induced thyroid disorders, with a focus on the various forms of clinical presentation and recommendations for personalized management of each form.<\/jats:p>","DOI":"10.1210\/clinem\/dgaa686","type":"journal-article","created":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T05:31:22Z","timestamp":1604727082000},"page":"226-236","source":"Crossref","is-referenced-by-count":68,"title":["Evaluation and Treatment of Amiodarone-Induced Thyroid Disorders"],"prefix":"10.1210","volume":"106","author":[{"given":"Dorina","family":"Ylli","sequence":"first","affiliation":[{"name":"Endocrine Section, MedStar Washington Hospital Center, Washington, DC"},{"name":"Faculty of Medicine, University of Medicine, Tirana, Albania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Wartofsky","sequence":"additional","affiliation":[{"name":"Endocrine Section, MedStar Washington Hospital Center, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8597-7213","authenticated-orcid":false,"given":"Kenneth D","family":"Burman","sequence":"additional","affiliation":[{"name":"Endocrine Section, MedStar Washington Hospital Center, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2020,11,7]]},"reference":[{"issue":"23","key":"2020122614311084900_CIT0001","doi-asserted-by":"crossref","first-page":"e740","DOI":"10.1161\/CIR.0000000000000613","article-title":"2018 American Heart Association focused update on advanced cardiovascular life support use of antiarrhythmic drugs during and immediately after cardiac arrest: an update to the American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care","volume":"138","author":"Panchal","year":"2018","journal-title":"Circulation."},{"issue":"11","key":"2020122614311084900_CIT0002","first-page":"2189","article-title":"Amiodarone: guidelines for use and monitoring","volume":"68","author":"Siddoway","year":"2003","journal-title":"Am Fam Physician."},{"issue":"12","key":"2020122614311084900_CIT0003","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.amjcard.2019.09.008","article-title":"Meta-analysis comparing the relative risk of adverse events for amiodarone versus placebo","volume":"124","author":"Ruzieh","year":"2019","journal-title":"Am J Cardiol."},{"issue":"1","key":"2020122614311084900_CIT0004","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrendo.2009.225","article-title":"Effects of amiodarone therapy on thyroid function","volume":"6","author":"Cohen-Lehman","year":"2010","journal-title":"Nat Rev Endocrinol."},{"issue":"1","key":"2020122614311084900_CIT0005","doi-asserted-by":"crossref","first-page":"63","DOI":"10.7326\/0003-4819-126-1-199701010-00009","article-title":"Effects of amiodarone on thyroid function","volume":"126","author":"Harjai","year":"1997","journal-title":"Ann Intern Med."},{"issue":"1","key":"2020122614311084900_CIT0006","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0735-1097(87)80098-0","article-title":"Thyroid dysfunction during chronic amiodarone therapy","volume":"9","author":"Albert","year":"1987","journal-title":"J Am Coll Cardiol."},{"issue":"1","key":"2020122614311084900_CIT0007","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/jcpt.13024","article-title":"Time-to-onset analysis of amiodarone-associated thyroid dysfunction","volume":"45","author":"Kinoshita","year":"2020","journal-title":"J Clin Pharm Ther."},{"issue":"5","key":"2020122614311084900_CIT0008","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0002-9343(91)90187-3","article-title":"Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism","volume":"91","author":"Trip","year":"1991","journal-title":"Am J Med."},{"issue":"1","key":"2020122614311084900_CIT0009","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/thy.1998.8.83","article-title":"Iodine-induced hyperthyroidism: occurrence and epidemiology","volume":"8","author":"Stanbury","year":"1998","journal-title":"Thyroid."},{"issue":"10","key":"2020122614311084900_CIT0010","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.amjmed.2007.04.022","article-title":"Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation","volume":"120","author":"Batcher","year":"2007","journal-title":"Am J Med."},{"issue":"4","key":"2020122614311084900_CIT0011","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2265.2007.02920.x","article-title":"Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy","volume":"67","author":"Bogazzi","year":"2007","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"3","key":"2020122614311084900_CIT0012","first-page":"340","article-title":"Amiodarone and the thyroid: a 2012 update","volume":"35","author":"Bogazzi","year":"2012","journal-title":"J Endocrinol Invest."},{"issue":"3","key":"2020122614311084900_CIT0013","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1159\/000444578","article-title":"Environmental iodine content, female sex and age are associated with new-onset amiodarone-induced hypothyroidism: a systematic review and meta-analysis of adverse reactions of amiodarone on the thyroid","volume":"134","author":"Zhong","year":"2016","journal-title":"Cardiology."},{"issue":"3","key":"2020122614311084900_CIT0014","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/2042018811398516","article-title":"Management of amiodarone-related thyroid problems","volume":"2","author":"Narayana","year":"2011","journal-title":"Ther Adv Endocrinol Metab."},{"issue":"12","key":"2020122614311084900_CIT0015","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/qjmed\/hcg158","article-title":"Men are at increased risk of amiodarone-associated thyrotoxicosis in the UK","volume":"96","author":"Sidhu","year":"2003","journal-title":"QJM."},{"key":"2020122614311084900_CIT0016","doi-asserted-by":"crossref","first-page":"534904","DOI":"10.1155\/2014\/534904","article-title":"Prevalence of amiodarone-induced thyrotoxicosis and associated risk factors in Japanese patients","volume":"2014","author":"Uchida","year":"2014","journal-title":"Int J Endocrinol."},{"issue":"1","key":"2020122614311084900_CIT0017","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-101-1-28","article-title":"Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy","volume":"101","author":"Martino","year":"1984","journal-title":"Ann Intern Med."},{"issue":"2","key":"2020122614311084900_CIT0018","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000486957","article-title":"2018 European Thyroid Association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction","volume":"7","author":"Bartalena","year":"2018","journal-title":"Eur Thyroid J."},{"issue":"1","key":"2020122614311084900_CIT0019","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/CCM.0000000000004078","article-title":"Thyroid storm in the ICU: a retrospective multicenter study","volume":"48","author":"Bourcier","year":"2020","journal-title":"Crit Care Med."},{"key":"2020122614311084900_CIT0020","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/978-3-319-72102-6_30","article-title":"Amiodarone-induced thyroid dysfunction","author":"De Leo","year":"2019","journal-title":"The Thyroid and Its Diseases."},{"issue":"7","key":"2020122614311084900_CIT0021","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.amjmed.2004.11.028","article-title":"Amiodarone and the thyroid","volume":"118","author":"Basaria","year":"2005","journal-title":"Am J Med."},{"issue":"732","key":"2020122614311084900_CIT0022","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/pgmj.62.732.909","article-title":"Amiodarone and thyroid hormone metabolism","volume":"62","author":"Wiersinga","year":"1986","journal-title":"Postgrad Med J."},{"issue":"3","key":"2020122614311084900_CIT0023","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1210\/endo-43-3-174","article-title":"The inhibitory action of excessive iodide upon the synthesis of diiodotyrosine and of thyroxine in the thyroid gland of the normal rat","volume":"43","author":"Wolff","year":"1948","journal-title":"Endocrinology."},{"issue":"2","key":"2020122614311084900_CIT0024","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12011-016-0723-2","article-title":"Effect of prolonged iodine overdose on type 2 iodothyronine deiodinase ubiquitination-related enzymes in the rat pituitary","volume":"174","author":"Zhang","year":"2016","journal-title":"Biol Trace Elem Res."},{"issue":"5","key":"2020122614311084900_CIT0025","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1017\/S0007114511003552","article-title":"Prolonged high iodine intake is associated with inhibition of type 2 deiodinase activity in pituitary and elevation of serum thyrotropin levels","volume":"107","author":"Li","year":"2012","journal-title":"Br J Nutr."},{"issue":"3","key":"2020122614311084900_CIT0026","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1210\/jcem-62-3-563","article-title":"Iodine kinetic studies during amiodarone treatment","volume":"62","author":"Rao","year":"1986","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2020122614311084900_CIT0027","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/archinte.1984.00350150071023","article-title":"Clinical and chemical assessment of thyroid function during therapy with amiodarone","volume":"144","author":"Amico","year":"1984","journal-title":"Arch Intern Med."},{"issue":"7","key":"2020122614311084900_CIT0028","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/archinte.1993.00410070068010","article-title":"Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. A possible consequence of a destructive process in the thyroid","volume":"153","author":"Roti","year":"1993","journal-title":"Arch Intern Med."},{"issue":"11","key":"2020122614311084900_CIT0029","first-page":"4323","article-title":"Amiodarone induces cytochrome c release and apoptosis through an iodine-independent mechanism","volume":"85","author":"Di Matola","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2020122614311084900_CIT0030","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1210\/endo.134.5.8156930","article-title":"Studies on the in vitro cytotoxic effect of amiodarone","volume":"134","author":"Chiovato","year":"1994","journal-title":"Endocrinology."},{"key":"2020122614311084900_CIT0031","author":"SRD.","year":"2020"},{"issue":"2","key":"2020122614311084900_CIT0032","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2265.1987.tb00781.x","article-title":"Amiodarone iodine-induced hypothyroidism: risk factors and follow-up in 28 cases","volume":"26","author":"Martino","year":"1987","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"1-2","key":"2020122614311084900_CIT0033","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1023\/A:1010004218052","article-title":"Iodine effects on the thyroid gland: biochemical and clinical aspects","volume":"1","author":"Burman","year":"2000","journal-title":"Rev Endocr Metab Disord."},{"issue":"6","key":"2020122614311084900_CIT0034","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1210\/jc.2010-0180","article-title":"Approach to the patient with amiodarone-induced thyrotoxicosis","volume":"95","author":"Bogazzi","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2020122614311084900_CIT0035","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/EJE-14-0267","article-title":"The onset time of amiodarone-induced thyrotoxicosis (AIT) depends on AIT type","volume":"171","author":"Tomisti","year":"2014","journal-title":"Eur J Endocrinol."},{"issue":"8","key":"2020122614311084900_CIT0036","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/BF03344178","article-title":"Long-term outcome of thyroid function after amiodarone-induced thyrotoxicosis, as compared to subacute thyroiditis","volume":"29","author":"Bogazzi","year":"2006","journal-title":"J Endocrinol Invest."},{"issue":"5","key":"2020122614311084900_CIT0037","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s40618-015-0426-0","article-title":"The presence of anti-thyroglobulin (TgAb) and\/or anti-thyroperoxidase antibodies (TPOAb) does not exclude the diagnosis of type 2 amiodarone-induced thyrotoxicosis","volume":"39","author":"Tomisti","year":"2016","journal-title":"J Endocrinol Invest."},{"issue":"4","key":"2020122614311084900_CIT0038","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000500355","article-title":"Plasma beta-glucuronidase activity: a novel tool to distinguish type 1 from type 2 amiodarone-induced thyrotoxicosis?","volume":"8","author":"Markantes","year":"2019","journal-title":"Eur Thyroid J."},{"issue":"7","key":"2020122614311084900_CIT0039","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1089\/105072503322239989","article-title":"The prevalence of elevated serum C-reactive protein levels in inflammatory and noninflammatory thyroid disease","volume":"13","author":"Pearce","year":"2003","journal-title":"Thyroid."},{"issue":"2","key":"2020122614311084900_CIT0040","first-page":"423","article-title":"Serum interleukin-6 in amiodarone-induced thyrotoxicosis","volume":"78","author":"Bartalena","year":"1994","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2020122614311084900_CIT0041","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.0300-0664.2001.01457.x","article-title":"Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography","volume":"56","author":"Eaton","year":"2002","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"2","key":"2020122614311084900_CIT0042","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/cen.12988","article-title":"Thyrotoxicosis associated with the use of amiodarone: the utility of ultrasound in patient management","volume":"84","author":"Theodoraki","year":"2016","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"4","key":"2020122614311084900_CIT0043","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1530\/EJE-08-0348","article-title":"The usefulness of 99mTc-sestaMIBI thyroid scan in the differential diagnosis and management of amiodarone-induced thyrotoxicosis","volume":"159","author":"Piga","year":"2008","journal-title":"Eur J Endocrinol."},{"issue":"1071","key":"2020122614311084900_CIT0044","doi-asserted-by":"crossref","first-page":"20160836","DOI":"10.1259\/bjr.20160836","article-title":"Evaluation of 99mTc-MIBI in thyroid gland imaging for the diagnosis of amiodarone-induced thyrotoxicosis","volume":"90","author":"Wang","year":"2017","journal-title":"Br J Radiol."},{"issue":"12","key":"2020122614311084900_CIT0045","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1089\/thy.2014.0028","article-title":"Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement","volume":"24","author":"Jacqueline Jonklaas","year":"2014","journal-title":"Thyroid"},{"issue":"2","key":"2020122614311084900_CIT0046","first-page":"240","article-title":"The effects of amiodarone on the thyroid","volume":"22","author":"Martino","year":"2001","journal-title":"Endocr Rev."},{"issue":"5","key":"2020122614311084900_CIT0047","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0002-9343(97)00047-8","article-title":"Lithium treatment in amiodarone-induced thyrotoxicosis","volume":"102","author":"Dickstein","year":"1997","journal-title":"Am J Med."},{"issue":"10","key":"2020122614311084900_CIT0048","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid."},{"issue":"7","key":"2020122614311084900_CIT0049","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.amjcard.2016.01.003","article-title":"Amiodarone-induced thyrotoxicosis recurrence after amiodarone reintroduction","volume":"117","author":"Maqdasy","year":"2016","journal-title":"Am J Cardiol."},{"issue":"10","key":"2020122614311084900_CIT0050","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1210\/jc.2009-0940","article-title":"Glucocorticoids are preferable to thionamides as first-line treatment for amiodarone-induced thyrotoxicosis due to destructive thyroiditis: a matched retrospective cohort study","volume":"94","author":"Bogazzi","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2020122614311084900_CIT0051","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1210\/jc.2002-021874","article-title":"Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study","volume":"88","author":"Bogazzi","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2020122614311084900_CIT0052","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1210\/jc.2011-2390","article-title":"Treatment of amiodarone-induced thyrotoxicosis type 2: a randomized clinical trial","volume":"97","author":"Eskes","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2020122614311084900_CIT0053","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2265.2008.03350.x","article-title":"Benzofuran derivatives and the thyroid","volume":"70","author":"Han","year":"2009","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"5","key":"2020122614311084900_CIT0054","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1530\/EJE-19-0515","article-title":"Pulsed intravenous methylprednisolone combined with oral steroids as a treatment for poorly responsive type 2 amiodarone-induced thyrotoxicosis","volume":"181","author":"Campi","year":"2019","journal-title":"Eur J Endocrinol."},{"issue":"11","key":"2020122614311084900_CIT0055","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s40618-020-01252-2","article-title":"Effect of high-dose intravenous glucocorticoid therapy on serum thyroid hormone concentrations in type 2 amiodarone-induced thyrotoxicosis: an exploratory study","volume":"43","author":"Cappellani","year":"2020","journal-title":"J Endocrinol Invest."},{"issue":"2","key":"2020122614311084900_CIT0056","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1210\/jc.2006-2059","article-title":"Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations","volume":"92","author":"Bogazzi","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"2020122614311084900_CIT0057","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1210\/jc.2011-1678","article-title":"Continuation of amiodarone delays restoration of euthyroidism in patients with type 2 amiodarone-induced thyrotoxicosis treated with prednisone: a pilot study","volume":"96","author":"Bogazzi","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2020122614311084900_CIT0058","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1507\/endocrj.K06-027","article-title":"Mild and short recurrence of type II amiodarone-induced thyrotoxicosis in three patients receiving amiodarone continuously for more than 10 years","volume":"53","author":"Sato","year":"2006","journal-title":"Endocr J."},{"issue":"12","key":"2020122614311084900_CIT0059","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrendo.2009.218","article-title":"Thyroid gland: use of glucocorticoids in amiodarone-induced thyrotoxicosis","volume":"5","author":"Vanderpump","year":"2009","journal-title":"Nat Rev Endocrinol."},{"issue":"1","key":"2020122614311084900_CIT0060","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1210\/clinem\/dgz041","article-title":"Comparison between total thyroidectomy and medical therapy for amiodarone-induced thyrotoxicosis","volume":"105","author":"Cappellani","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2020122614311084900_CIT0061","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000453578","article-title":"Successful pretreatment using plasma exchange before thyroidectomy in a patient with amiodarone-induced thyrotoxicosis","volume":"6","author":"Tonnelier","year":"2017","journal-title":"Eur Thyroid J."},{"key":"2020122614311084900_CIT0062","first-page":"160039","article-title":"Plasma exchange in the treatment of thyroid storm secondary to type II amiodarone-induced thyrotoxicosis","volume":"2016","author":"Zhu","year":"2016","journal-title":"Endocrinol Diabetes Metab Case Rep."},{"issue":"12","key":"2020122614311084900_CIT0063","doi-asserted-by":"crossref","first-page":"695","DOI":"10.20452\/pamw.2556","article-title":"Radioiodine therapy in patients with type II amiodarone-induced thyrotoxicosis","volume":"124","author":"Czarnywojtek","year":"2014","journal-title":"Pol Arch Med Wewn."},{"issue":"5","key":"2020122614311084900_CIT0064","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1365-2265.2008.03405.x","article-title":"Recombinant human TSH as an adjuvant to radioiodine for the treatment of type 1 amiodarone-induced thyrotoxicosis (AIT)","volume":"70","author":"Albino","year":"2009","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"12","key":"2020122614311084900_CIT0065","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1253\/circj.CJ-13-0220","article-title":"Amiodarone-induced thyrotoxicosis late after amiodarone withdrawal","volume":"77","author":"Yagishita","year":"2013","journal-title":"Circ J."},{"issue":"8","key":"2020122614311084900_CIT0066","first-page":"2930","article-title":"Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study","volume":"81","author":"Bartalena","year":"1996","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2020122614311084900_CIT0067","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/01.md.0000123095.65294.34","article-title":"Complex drug-drug-disease interactions between amiodarone, warfarin, and the thyroid gland","volume":"83","author":"Kurnik","year":"2004","journal-title":"Medicine (Baltimore)."},{"issue":"6","key":"2020122614311084900_CIT0068","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.4158\/EP13093.RA","article-title":"Effects of amiodarone, thyroid hormones and CYP2C9 and VKORC1 polymorphisms on warfarin metabolism: a review of the literature","volume":"19","author":"Tomisti","year":"2013","journal-title":"Endocr Pract."},{"issue":"3","key":"2020122614311084900_CIT0069","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1124\/dmd.116.073890","article-title":"Application of static modelingin the prediction of in vivo drug\u2013drug interactions between rivaroxaban and antiarrhythmic agents based on in vitro inhibition studies","volume":"45","author":"Cheong","year":"2017","journal-title":"Drug Metab Dispos."},{"issue":"4","key":"2020122614311084900_CIT0070","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s11239-020-02037-3","article-title":"The real world use of combined P-glycoprotein and moderate CYP3A4 inhibitors with rivaroxaban or apixaban increases bleeding","volume":"49","author":"Hanigan","year":"2020","journal-title":"J Thromb Thrombolysis."},{"issue":"4","key":"2020122614311084900_CIT0071","first-page":"376","article-title":"Simultaneous use of amiodarone influences warfarin maintenance dose but is not associated with adverse events","volume":"20","author":"Santos","year":"2014","journal-title":"J Manag Care Spec Pharm."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/106\/1\/226\/35175107\/dgaa686.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/106\/1\/226\/35175107\/dgaa686.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T22:30:32Z","timestamp":1723847432000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/106\/1\/226\/5959942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,7]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,11,7]]},"published-print":{"date-parts":[[2021,1,1]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaa686","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,1,1]]},"published":{"date-parts":[[2020,11,7]]}}}